Moderna, Inc.

Ownership Transactions Reported by 21 Insiders

Symbol
MRNA on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
325 Binney Street, Cambridge, MA

Insiders trading volume in the past year

Moderna, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Noubar Afeyan Director $834M Apr 30, 2025
Stephane Bancel Chief Executive Officer, Director $464M +$5M +1.09% Mar 3, 2025
Stephen Hoge President $44.6M -$38.8K -0.09% Aug 29, 2025
Paul Sagan Director $15.7M +$1M +6.84% Apr 30, 2025
Stephen Berenson Director $2.52M May 3, 2024
Juan Andres Chief Technical Operations and Quality Officer $2.23M Dec 28, 2022
Arpa Garay Chief Commercial Officer $1.52M Dec 5, 2023
James M. Mock Chief Financial Officer $738K -$104K -12.3% Aug 27, 2025
Shannon Thyme Klinger Chief Legal Officer $725K -$89.2K -10.9% Aug 29, 2025
David Meline Chief Financial Officer $645K Aug 9, 2022
Paul Burton Chief Medical Officer $542K Nov 4, 2022
Elizabeth G. Nabel Director $193K Apr 30, 2025
Sandra Horning Director $174K Apr 30, 2025
David M. Rubenstein Director $119K Aug 5, 2025
Lori M. Henderson General Counsel and Secretary $93.6K May 27, 2021
Abbas Hussain Director $81.9K -$8.74K -9.64% Jun 11, 2025
Jorge M. Gomez Officer May 9, 2022
Francois Nader Director Apr 30, 2025
Tal Zvi Zaks Chief Medical Officer Jun 30, 2021
Robert Langer Director May 6, 2024
Elizabeth E. Tallett Director Apr 30, 2025

Recent Insider Transactions by Companies or Individuals for Moderna, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.